ClinicalTrials.gg
Drug

Artenimol clinical trials

Also written Dihydroartemisinin.

studies test it
91
open now
10
in phase 3
34
first study started
2003

How each study uses artenimol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the artenimol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
27 Oct 2011 · Eurartesim · EMEA/H/C/001199 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Other names

Dihydroartemisinin
7

In one entry with another drug

Given together, or one or the other

Dihydroartemisinin-piperaquine
40
Eurartesim
21
Dihydroartemisinin-piperaquine (DP)
10
Dihydroartemisinin piperaquine
9
Artekin
9
Duo-Cotecxin
8
D-Artepp
7
DuoCotecxin
4

Studies by the year they started

91 studies that test it; most in 2010 (9)

Studies that test artenimol, by start year
YearStudies
20031
20074
20082
20091
20109
20113
20124
20138
20146
20156
20163
20173
20184
20194
20204
20215
20227
20232
20245
20254
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
5
Phase 2
10
Phase 3
34
Phase 4
30
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 84

University of California, San Francisco (7) · London School of Hygiene and Tropical Medicine (7) · University of Oxford (7) · Liverpool School of Tropical Medicine (6) · Shanghai Zhongshan Hospital (4) · National Institute for Medical Research, Tanzania (4) · sigma-tau i.f.r. S.p.A. (3) · University of North Carolina, Chapel Hill (2)

Often tested with

Tested in the same studies.

Piperaquine (83) · Fanasil, pyrimethamine drug combination (10) · Artemether, Lumefantrine Drug Combination (10) · Amodiaquine (9) · Chloroquine (6) · Artesunate (5) · Primaquine (3) · Mefloquine (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test artenimol, phase 3 first.

Studies

Open first, then newest update. How each study uses artenimol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 91

See all 91 studies that test artenimol →

Given beside what is tested · 10 — artenimol is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with artenimol

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call artenimol · ClinicalTrials.gg INT003114

  • MeSH (NLM) C039060artenimolConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 6A9O50735XARTENIMOLConfirmed FDA, NLM
  • NCI Thesaurus C87432ArtenimolOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.